DMKJ
COLL icon

David M. Knott Jr’s Collegium Pharmaceutical COLL Stock Holding History

David M. Knott Jr’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,511
Closed -$695K – 91
2025
Q2 		$695K Sell
23,511
-14,962
-39% -$427K 0.32% 40
2025
Q1 		$1.15M Buy
38,473
+5,546
+17% +$169K 0.54% 28
2024
Q4 		$943K Buy
+32,927
New +$1.09M 0.34% 30

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

David M. Knott Jr's COLL Position: Q3 2025 in Review

David M. Knott Jr sold out of Collegium Pharmaceutical (COLL) in Q3 2025, closing a stake of 23,511 shares — an estimated $695K sold.

David M. Knott Jr first reported a position in COLL in Q4 2024 and held it in 3 quarters. The position peaked at $1.15M in Q1 2025. 244 funds tracked by Wall St. Rank hold COLL as of Q3 2025.

  • David M. Knott Jr reported no remaining Collegium Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • David M. Knott Jr sold 23,511 Collegium Pharmaceutical shares in Q3 2025, an estimated $695K.
  • David M. Knott Jr first reported a position in Collegium Pharmaceutical in Q4 2024 and held it in 3 quarters.
  • David M. Knott Jr's Collegium Pharmaceutical position peaked at $1.15M in Q1 2025.
  • 244 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2025.

Based on David M. Knott Jr's 13F filing for Q3 2025, filed 12 Nov 2025.